ACE and diabetes mellitus: The comparator was placebo or standard of care, which generally included background therapies consistent with guideline-directed medical treatment for diabetes and cardiovascular risk reduction (e.g., metformin, statins, angiotensin converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs), and antiplatelet therapy, as applicable).